Jeffrey J. Bird
Known title: President & COOCIK: 0001626272
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
INVX shows strong growth and favorable technical setup. Innovex International reported strong recent growth, which the ChartMill analysis highlighted alongside a technically favorable chart pattern. The stock is near a key support level at $27.31 and shows a positive RSI divergence and a touch of the 200‑day moving average. These elements suggest the recent performance is supported by both fundamentals and technical indicators.
Transaction History
| ASIX | ▲ Buy | Grant | 6,207 | $0 | 6/22/2026 | View on chart |
| INVX | ▲ Buy | Grant | 151,046 | — | 9/6/2024 | View on chart |
| INVX | ▼ Sell | Tax Withholding | 59,438 | $916K | 9/6/2024 | View on chart |
| INVX | ▼ Sell | Tax Withholding | 41,251 | $636K | 9/6/2024 | View on chart |
| INVX | ▼ Sell | Open Market | 7,500 | $174K | 4/1/2024 | View on chart |
| INVX | ▼ Sell | Open Market | 7,500 | $174K | 1/2/2024 | View on chart |
| INVX | ▲ Buy | Grant | 54,872 | $0 | 10/28/2023 | View on chart |
| INVX | ▼ Sell | Tax Withholding | 16,189 | $369K | 10/28/2023 | View on chart |
| INVX | ▼ Sell | Open Market | 2,500 | $75K | 4/3/2023 | View on chart |
| INVX | ▼ Sell | Open Market | 2,324 | $61K | 1/3/2023 | View on chart |
| INVX | ▼ Sell | Open Market | 176 | $5K | 1/3/2023 | View on chart |
| INVX | ▼ Sell | Open Market | 2,336 | $56K | 10/31/2022 | View on chart |
| INVX | ▼ Sell | Open Market | 11,212 | $275K | 10/31/2022 | View on chart |
| INVX | ▲ Buy | Grant | 53,694 | $0 | 10/28/2022 | View on chart |
| INVX | ▼ Sell | Open Market | 2,500 | $52K | 10/3/2022 | View on chart |
| INVX | ▼ Sell | Open Market | 2,307 | $58K | 7/1/2022 | View on chart |
| INVX | ▼ Sell | Open Market | 193 | $5K | 7/1/2022 | View on chart |
| INVX | ▼ Sell | Open Market | 4,283 | $158K | 4/1/2022 | View on chart |
| INVX | ▼ Sell | Open Market | 717 | $27K | 4/1/2022 | View on chart |
| INVX | ▼ Sell | Open Market | 528 | $11K | 1/3/2022 | View on chart |
| INVX | ▼ Sell | Open Market | 4,472 | $94K | 1/3/2022 | View on chart |
| INVX | ▼ Sell | Open Market | 17,216 | $393K | 10/29/2021 | View on chart |
| INVX | ▼ Sell | Open Market | 136 | $3K | 10/29/2021 | View on chart |
| INVX | ▲ Buy | Grant | 42,480 | $0 | 10/28/2021 | View on chart |
| INVX | ▲ Buy | Grant | 10,443 | $0 | 10/28/2021 | View on chart |
| INVX | ▼ Sell | Open Market | 3,357 | $87K | 10/1/2021 | View on chart |
| INVX | ▼ Sell | Open Market | 1,643 | $43K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge
AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.
AdvanSix Featured in Chemical Stocks With Natural Gas Cost Edge. AdvanSix (ASIX) was included in a recent article highlighting three US chemical stocks that benefit from lower natural gas costs. This cost advantage is relevant to the company's production expenses in the specialty chemicals sector. The stock is currently trading below its average analyst target price, with a 52-week range extending from $14.10 to $26.73.